Metraipolis › archive › dc_29043f9f640a

Performance Assessment of μTASWako i50, a New Microfluidic Immunoassay System for Hepatocellular Carcinoma Biomarkers AFP, AFP-L3%, and PIVKA-II — Europe PMC PMID:41869214

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41869214
DOI
10.7759/cureus.103793
License (as archived)
solo-consultazione
Archived
2026-11-05T17:42:57.115Z
SHA-256 of the archived text
c0613d5b6063691f4565498732a9aa966b86f3ab2bd919af1983e55c28166529
Stable URL of this page
https://metraipolis.com/documento/dc_29043f9f640a

How to cite

Performance Assessment of μTASWako i50, a New Microfluidic Immunoassay System for Hepatocellular Carcinoma Biomarkers AFP, AFP-L3%, and PIVKA-II — Europe PMC PMID:41869214 — Europe PMC (en), https://europepmc.org/article/MED/41869214 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_29043f9f640a (Metraipolis archive dc_29043f9f640a, sha256 c0613d5b6063691f4565498732a9aa966b86f3ab2bd919af1983e55c28166529)
BibTeX
@misc{dc29043f9f640a,
  title = {Performance Assessment of μTASWako i50, a New Microfluidic Immunoassay System for Hepatocellular Carcinoma Biomarkers AFP, AFP-L3%, and PIVKA-II — Europe PMC PMID:41869214},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41869214},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_29043f9f640a; sha256 c0613d5b6063691f4565498732a9aa966b86f3ab2bd919af1983e55c28166529},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41869214. Agents can read the archived copy with the MCP tool read_document.